Skip to content
★ Sign in to follow
MD

Martin Doordan

Executive
Total declarations
7
Company
1
▲ Purchases (4 ops.)
€46k
▼ Sales (0 ops.)
—

Latest filing published 05 Jun 2012 for Dexcom Inc.

Insider track record

Disclosed buys
4
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
4
Positive at T+90
75%
Median T+90
+13.6%

Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 12 Mar 2012 · 5355 days ago · €7,869
    +61.3%
    Entry US$2.60 · Close at T+365 US$4.19
  • Filed 15 Dec 2011 · 5443 days ago · €12k
    +63.0%
    Entry US$2.03 · Close at T+365 US$3.31
  • Filed 19 Sept 2011 · 5530 days ago · €18k
    +16.9%
    Entry US$3.15 · Close at T+365 US$3.68

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Martin Doordan: trading record in brief

Martin Doordan is a declared insider of Dexcom Inc, with filings sourced from SEC (Form 4). In total, 7 filings cover trades dated from 26 May 2011 to 1 June 2012.

On the market, this insider has only ever bought: 4 purchases, €46k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 3 share grants. 2012 to date brings 2 purchases and no sales.

Half of the purchases are above €10k and half below. For 4 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 75% of cases, with a median move of +13.6%. They describe history only and say nothing certain about the share price ahead.

The newest entry dates from 5 June 2012: a share grant, in Dexcom Inc. The latest purchase dates back some time: it was published 5,355 days ago, on 12 March 2012. Typically, a trade is published a median of 4 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Martin Doordan

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations7 total
  • ◆
    DirectorExecutivesDexcom Inc
    0SEC
    17,992 shares0Common StockSEC:0001093557-12-000035:0
  • ▲
    DirectorExecutivesDexcom Inc
    10,340 USD0SEC
    1,000 shares@ US$10.34Common StockSEC:0001093557-12-000008:0
    Canonical exit: 6 Jun 2012 (T+90)
  • ▲
    DirectorExecutivesDexcom Inc
    10,370 USD0SEC
    1,000 shares@ US$10.37Common StockSEC:0001093557-12-000008:1
    Canonical exit: 6 Jun 2012 (T+90)
  • ▲
    DirectorExecutivesDexcom Inc
    16,060 USD0SEC
    2,000 shares@ US$8.03Common StockSEC:0001093557-11-000044:0
    Canonical exit: 12 Mar 2012 (T+90)
  • ▲
    DirectorExecutivesDexcom Inc
    24,700 USD0SEC
    2,000 shares@ US$12.35Common StockSEC:0001093557-11-000040:0
    Canonical exit: 14 Dec 2011 (T+90)
  • ◆
    DirectorExecutivesDexcom Inc
    0SEC
    1,967 shares0Common StockSEC:0001093557-11-000031:0
  • ◆
    DirectorExecutivesDexcom Inc
    0SEC
    19,674 shares0Common StockSEC:0001093557-11-000031:1

7 of 7 declarations